– Vuzix receives order for M400 smart glasses from Pixee Medical
ROCHESTER, NY, September 17, 2021 / PRNewswire / – Vuzix® Company (NASDAQ: VUZI), (“Vuzix” or the “Company”), a leading provider of smart glasses and augmented reality (AR) technologies and products, today announced that the Vuzix M400 smart glasses were recently presented in a clinical pilot study that examined the accuracy of Pixee Medical Knee + augmented reality navigation in performing total knee arthroplasty (TKA). The preliminary results of the study, as discussed in the article published in the Journal of Experimental Orthopedics, found that the Knee + system is precise and efficient for performing PTG, and that the translation of a pilot study into high-level prospective studies is warranted to assess the accuracy and cost-benefit analysis compared to conventional techniques.
Pixee Medical has now shipped more than 100 Knee + systems, which allow the surgeon to visualize the tibial and femur axis superimposed on the operating field using smart glasses. It provides real-time information during surgery and intraoperative feedback. The surgeon can choose the varus / valgus angle and posterior slope in tibial cut, distal femoral cut in valgus and flexion / extension of the femoral component on the femoral side.
In addition, to support the marketing and deployment of the augmented reality navigation system in the US market, Pixee Medical placed an order for M400 smart glasses which was delivered during the third quarter.
The full review article can be accessed via this link: https://jeo-esska.springeropen.com/articles/10.1186/s40634-021-00374-7.
“Pixele Medical’s Knee + Total Knee Arthroplasty product is a scalable solution that continues to meet the needs of surgeons and provides advanced, easy-to-use technology. We plan to expand rapidly around the world, and a next step will be to enter the United States with a focus on the growing outpatient surgery center (ASC) market. Our attractive AR smart glasses product is affordable and does not require consumable management, ”commented Sébastien Henry, Founding President of Pixee Medical.
Pixee Medical continues to make great strides in supporting the surgical community with its innovative Knee + AR solution, with a growing installed base in Europe and US operations are only just beginning, ”said Paul Travers, President and CEO of Vuzix.
About Vuzix Corporation
Vuzix is a leading provider of smart glasses and augmented reality (AR) technologies and products for the consumer and enterprise markets. The Company’s products include personal displays and portable computing devices that provide users with a high-quality portable viewing experience, provide solutions for mobility, portable displays and augmented reality. Vuzix holds 210 patents and pending patents and numerous IP licenses in the field of video eyewear. The company has won innovation awards at the Consumer Electronics Show (or CES) for the years 2005 to 2021 and several innovation awards in wireless technology, among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in Rochester, New York, Oxford, United Kingdom, and Tokyo, Japan. For more information, visit the Vuzix website, Twitter and Facebook pages.
Disclaimer Regarding Forward-Looking Statements
Certain statements contained in this press release are “forward-looking statements” within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. The forward-looking statements contained in this press release relate to Vuzix smart glasses, our business relationship and future opportunities with Pixee Medical, and among other things the company’s leadership in the smart glasses and AR display industry. They are usually identified by words such as “believes”, “may”, “expects”, “anticipates”, “should” and similar expressions. Readers should not place undue reliance on these forward-looking statements, which are based on the Company’s beliefs and assumptions as of the date of this release. The actual results of the Company could differ materially due to risk factors and other items described in more detail in the “Risk Factors” section of the Company’s annual reports and MD&A filed with the Securities and Exchange. Commission of applicable United States and Canadian Securities Regulatory Authorities (copies of which can be obtained at www.sedar.com Where www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changes in events or circumstances occurring after the date of this press release, except as required by applicable law.
Vuzix media and investor relations contact:
Ed McGregor, Director of Investor Relations,
Phone. : (585) 359-5985
View original content to download multimedia:https://www.prnewswire.com/news-releases/clinical-pilot-study-confirms-the-accuracy-and-effectiveness-of-pixee-medicals-knee-solution-using-vuzix-m400-smart-glasses- for-total-knee-arthroplasty-301379539.html
SOURCE Vuzix Corporation